Similar articles for PMID: 9796763

Year	Number of Results
1909	1
1946	1
1948	1
1984	1
1997	4
1998	1
2000	3
2001	1
2002	3
2003	6
2004	1
2005	3
2006	4
2007	7
2008	4
2009	8
2010	6
2011	7
2012	4
2013	5
2014	7
2015	7
2016	8
2017	12
2018	6
2021	5

1

Use of colchicine to treat severe constipation in developmentally disabled patients.

Frame PS, Dolan P, Kohli R, Eberly SW. Frame PS, et al. J Am Board Fam Pract. 1998 Sep-Oct;11(5):341-6. doi: 10.3122/15572625-11-5-341. J Am Board Fam Pract. 1998. PMID: 9796763 Clinical Trial.

2

Treatment of chronic constipation with colchicine: randomized, double-blind, placebo-controlled, crossover trial.

Verne GN, Davis RH, Robinson ME, Gordon JM, Eaker EY, Sninksy CA. Verne GN, et al. Am J Gastroenterol. 2003 May;98(5):1112-6. doi: 10.1111/j.1572-0241.2003.07417.x. Am J Gastroenterol. 2003. PMID: 12809836 Clinical Trial.

3

Colchicine is an effective treatment for patients with chronic constipation: an open-label trial.

Verne GN, Eaker EY, Davis RH, Sninsky CA. Verne GN, et al. Dig Dis Sci. 1997 Sep;42(9):1959-63. doi: 10.1023/a:1018883731556. Dig Dis Sci. 1997. PMID: 9331162 Clinical Trial.

4

Cisapride for the treatment of constipation in children: A double-blind study.

Nurko S, Garcia-Aranda JA, Worona LB, Zlochisty O. Nurko S, et al. J Pediatr. 2000 Jan;136(1):35-40. doi: 10.1016/s0022-3476(00)90046-5. J Pediatr. 2000. PMID: 10636971 Clinical Trial.

5

Cochrane Review: Osmotic and stimulant laxatives for the management of childhood constipation (Review).

Gordon M, Naidoo K, Akobeng AK, Thomas AG. Gordon M, et al. Evid Based Child Health. 2013 Jan;8(1):57-109. doi: 10.1002/ebch.1893. Evid Based Child Health. 2013. PMID: 23878124 Review.

6

A placebo-controlled trial of prucalopride for severe chronic constipation.

Camilleri M, Kerstens R, Rykx A, Vandeplassche L. Camilleri M, et al. N Engl J Med. 2008 May 29;358(22):2344-54. doi: 10.1056/NEJMoa0800670. N Engl J Med. 2008. PMID: 18509121 Free article. Clinical Trial.

7

Safety and efficacy of elobixibat for chronic constipation: results from a randomised, double-blind, placebo-controlled, phase 3 trial and an open-label, single-arm, phase 3 trial.

Nakajima A, Seki M, Taniguchi S, Ohta A, Gillberg PG, Mattsson JP, Camilleri M. Nakajima A, et al. Lancet Gastroenterol Hepatol. 2018 Aug;3(8):537-547. doi: 10.1016/S2468-1253(18)30123-7. Epub 2018 May 25. Lancet Gastroenterol Hepatol. 2018. PMID: 29805116 Clinical Trial.

8

Linaclotide in Chronic Idiopathic Constipation Patients with Moderate to Severe Abdominal Bloating: A Randomized, Controlled Trial.

Lacy BE, Schey R, Shiff SJ, Lavins BJ, Fox SM, Jia XD, Blakesley RE, Hao X, Cronin JA, Currie MG, Kurtz CB, Johnston JM, Lembo AJ. Lacy BE, et al. PLoS One. 2015 Jul 29;10(7):e0134349. doi: 10.1371/journal.pone.0134349. eCollection 2015. PLoS One. 2015. PMID: 26222318 Free PMC article. Clinical Trial.

9

Tegaserod for the treatment of irritable bowel syndrome and chronic constipation.

Evans BW, Clark WK, Moore DJ, Whorwell PJ. Evans BW, et al. Cochrane Database Syst Rev. 2007 Oct 17;(4):CD003960. doi: 10.1002/14651858.CD003960.pub3. Cochrane Database Syst Rev. 2007. PMID: 17943807 Review.

10

Fixed ratio (2:1) prolonged-release oxycodone/naloxone combination improves bowel function in patients with moderate-to-severe pain and opioid-induced constipation refractory to at least two classes of laxatives.

Koopmans G, Simpson K, De Andrés J, Lux EA, Wagemans M, Van Megen Y. Koopmans G, et al. Curr Med Res Opin. 2014 Nov;30(11):2389-96. doi: 10.1185/03007995.2014.971355. Epub 2014 Oct 13. Curr Med Res Opin. 2014. PMID: 25265132 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed